📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Double-blind, randomized phase III study to compare the efficacy and safety of CT-P6, trastuzumab biosimilar candidate versus trastuzumab as neoadjuvant treatment in HER2 positive early breast cancer (EBC). (2017)

First Author: Stebbing J

Attributed to: Identification, roles and mechanisms of long non-coding RNAs in stem cells and metastasis in breast cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.2017.35.15_suppl.510

Publication URI: http://dx.doi.org/10.1200/jco.2017.35.15_suppl.510

Type: Journal Article/Review

Parent Publication: Journal of Clinical Oncology

Issue: 15_suppl